deltatrials
Completed NA INTERVENTIONAL 2-arm NCT02848170

Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension

An Exploratory Study of CS-3150 to Evaluate the Relation Between Antihypertensive Effect and Baseline Factors Compared to Olmesartan Medoxomil in Patients With Essential Hypertension

Sponsor: Daiichi Sankyo Co., Ltd.

Conditions Essential Hypertension
Interventions CS-3150 olmesartan medoxomil
Updated 11 times since 2017 Last updated: Dec 19, 2018 Started: Aug 31, 2016 Primary completion: Apr 30, 2017 Completion: Apr 30, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Essential Hypertension and is currently completed. Daiichi Sankyo Co., Ltd. leads this study, which shows 11 recorded versions since 2016 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~May 2017 · 3 months · monthly snapshotRecruiting~May 2017 – ~Jun 2017 · 31 days · monthly snapshotActive Not Recruiting~Jun 2017 – ~Sep 2017 · 3 months · monthly snapshotCompleted~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshotCompleted~Jan 2019 – ~Jan 2021 · 24 months · monthly snapshotCompleted~Jan 2021 – ~Mar 2024 · 38 months · monthly snapshotCompleted~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Mar 2024 — Jul 2024 [monthly]

    Completed NA

  4. Jan 2021 — Mar 2024 [monthly]

    Completed NA

  5. Jan 2019 — Jan 2021 [monthly]

    Completed NA

▶ Show 6 earlier versions

  1. Jun 2018 — Jan 2019 [monthly]

    Completed NA

  2. Sep 2017 — Jun 2018 [monthly]

    Completed NA

  3. Jun 2017 — Sep 2017 [monthly]

    Completed NA

    Status: Active Not Recruiting → Completed · Phase: PHASE3 → NA

  4. May 2017 — Jun 2017 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  5. Feb 2017 — May 2017 [monthly]

    Recruiting PHASE3

  6. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE3

    First recorded

Aug 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Daiichi Sankyo Co., Ltd.
Data source: Daiichi Sankyo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations